Xeris Biopharma Holdings, Inc. XERS EV / sales
EV / sales at other companies
Other financials
Where this comes from
Calculated from Xeris Biopharma Holdings, Inc.’s reported figures.
Based on the most recent quarter.
The official record: Xeris Biopharma Holdings, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Xeris Biopharma Holdings, Inc.'s ev / sales.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Xeris Biopharma Holdings, Inc.'s EV / sales?
- Xeris Biopharma Holdings, Inc. (XERS) reported EV / sales of 3.6× in Q1 2026.
- How has Xeris Biopharma Holdings, Inc.'s EV / sales changed year-over-year?
- Xeris Biopharma Holdings, Inc.'s EV / sales decreased by 23.2% year-over-year, from 4.7× to 3.6×.
- What is the long-term trend for Xeris Biopharma Holdings, Inc.'s EV / sales?
- Over 4 years (2021 to 2025), Xeris Biopharma Holdings, Inc.'s EV / sales has grown at a -10.6% compound annual growth rate (CAGR), from 7.8× to 5×.
- What does EV / sales mean?
- Enterprise value at the quarter end divided by trailing-twelve-month revenue. A capital-structure-neutral revenue multiple, useful when earnings are negative.